S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

AIM ImmunoTech (AIM) Earnings Date, Estimates & Call Transcripts

$0.47
-0.01 (-2.09%)
(As of 04/18/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

AIM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AIM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AIM Earnings Date and Information

AIM ImmunoTech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

AIM ImmunoTech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)
------- 
11/15/2023Q3 2023($0.11)($0.16)($0.05)($0.16)-$0.05 million
8/15/2023Q2 2023-($0.10)($0.10)($0.10)-$0.04 million
5/12/2023Q1 2023-($0.08)($0.08)($0.08)-$0.05 million
4/3/2023Q4 2022-($0.09)($0.09)($0.09)-$0.06 million
11/15/2022Q3 2022-($0.13)($0.13)($0.13)-$0.02 million
8/15/2022Q2 2022-($0.10)($0.10)($0.10)-$0.03 million
5/16/2022Q1 2022-($0.08)($0.08)($0.08)-$0.03 million
3/31/2022Q4 2021-($0.12)($0.12)($0.12)-$0.05 million
11/16/2021Q3($0.0750)($0.08)($0.0050)($0.08)-$0.03 million
8/15/2021Q2($0.0830)($0.12)($0.0370)($0.12)-$0.02 million
5/18/2021Q1($0.0870)($0.08)+$0.0070($0.08)-$0.03 million

AIM ImmunoTech Earnings - Frequently Asked Questions

When is AIM ImmunoTech's earnings date?

AIM ImmunoTech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on AIM's earnings history.

How much revenue does AIM ImmunoTech generate each year?

AIM ImmunoTech (NYSE:AIM) has a recorded annual revenue of $200,000.00.

How much profit does AIM ImmunoTech generate each year?

AIM ImmunoTech (NYSE:AIM) has a recorded net income of -$28.96 million. AIM has generated -$0.60 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

This page (NYSE:AIM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners